AHA/PRT Spina Outcomes Research Postdoctoral Fellowships- Round 3

Updated:Feb 11,2013

AHA/PRT-Spina Outcomes Research Postdoctoral Fellowships - Round Three

Pharmaceutical RoundtableCall for Expressions of Interest
The American Heart Association/Pharmaceutical Roundtable-Spina Outcomes Research Centers invite applications fortwo-year postdoctoral fellowships (beginning in July 2011). Successful candidates will be notified by April 1, 2011.

Fellows must have an M.D., Ph.D., D.O., or equivalent doctoral degree and must be U.S. citizens, permanent residents, pending permanent residents, or hold one of the following visa statuses: E-3, F-1, H1-B, J-1, O-1, or TN. Fellows must commit a minimum of 75 percent of time to research training. Fellows may not hold a faculty or staff appointment, with the exception of M.D.'s or M.D./Ph.D's with clinical responsibilities. Fellows may hold a title of instructor or similar due to their patient care responsibilities. Fellows may not hold another fellowship award. A named fellow may have been a recipient of an AHA fellowship, but may not hold an AHA affiliate fellowship or AHA Fellow-to-Faculty Transition Award at the same time as an AHA/PRT-Spina Outcomes Research Center fellowship.

Applicants should be exceptional and highly motivated andseek advanced research training and experience to become leaders in cardiovascular disease or stroke outcomes research. The AHA/PRT-Spina Outcomes Research Centers' Fellowship Training Programs are intensive experiences that will prepare post-doctoral scholars for careers in outcomes research. All centers' training programs include substantial protected time for research and formal mentorship from experienced faculty. Fellows will design and complete one or more independent research studies during their fellowship. Each training program also includes opportunities for didactic training, as well as cross-center training through a collaborative network that the four centers have established for research training.

General nature of AHA-PRT Outcomes Centers' research studies:

Duke University

  • Improving transitional care for patients with coronary disease, myocardial infarction and heart failure

Mid America Heart Institute, Kansas City, Mo.

  • Developing novel strategies to translate individualized, patient-centered, risk prediction models into the process of routine clinical care

Stanford University-Kaiser Permanente

  • Defining and delivering optimal therapy for ischemic heart disease and chronic heart failure in routine practice

University of California, Los Angeles

  • Reducing stroke occurrence and improving stroke outcomes in vulnerable populations

Applicants should contact the appropriate person below for additional application procedures. Deadline for all candidates is Jan. 31, 2011.

Duke University
Durham, N.C.

Eric Peterson, M.D., M.P.H.
c/o Patsy Clifton, Program Coordinator
2400 Pratt St, Room 7009
Duke Clinical Research Institute (DCRI)
Durham, NC 27514
Phone: (919) 668-8744
E-mail: patsy.clifton@duke.edu

Mid America Heart Institute
Kansas City, Mo.

John Spertus, M.D., M.P.H. (Center Director), and Mikhail Kosiborod, M.D. (Training Director)
5th Floor Mid America Heart Institute
4401 Wornall Road
Kansas City, MO 64111
Phone: (816) 932-5475
Fax: (816) 932-5613
E-mail: mkosiborod@cc-pc.com.

Stanford University-Kaiser Permanente
Stanford and Oakland, Calif.

Mark Hlatky, M.D., and Alan S. Go, M.D. (Co-Directors)
c/o Elaine Steel
Stanford University School of Medicine
HRP Redwood Building, Room 150
Stanford, CA 94305-5405
Phone: (650) 723-6426
E-mail: steel@stanford.edu

University of California, Los Angeles
Los Angeles, Calif.

Barbara Vickrey, M.D., M.P.H., Center Director
c/o France Nguyen-Grozavu, Ph.D., M.P.H., M.A.
UCLA Dept of Neurology
C-109 RNRC; Box 951769
Los Angeles, CA 90095-1769
Phone: (310) 206-7671 Fax: (310) 794-7716
E-mail: fnguyen@ucla.edu
Website for Application: https://sites.google.com/site/uclaahaprtspinaorc/